We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lax Validations, Risk Analysis Cited at Florida Facility
Lax Validations, Risk Analysis Cited at Florida Facility
The FDA found Anodyne Therapy’s validation and risk analyses were inadequate, and reports of radiation were not sent to the FDA, according to a 483 the firm received follow an agency inspection of its Oldsmar, Florida facility.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor